Artificial intelligence enabled ECG screening for left ventricular systolic dysfunction: a systematic review.

Detecting weakened heart pumping remains a significant challenge for modern clinical practice. Prior research has shown that early identification of this condition allows for timely medical intervention. No prior work had resolved the full diagnostic potential of automated rhythm analysis. That uncertainty drove the need for a comprehensive assessment of current evidence. Many clinicians struggle to identify patients who might benefit from advanced cardiac imaging. This gap motivated a deeper look at how machine learning might assist in routine care. Existing screening methods often lack the efficiency required for broad population health management. Scholars have long sought better ways to utilize routine heart electrical data for preventative purposes.

The aim of this review is to outline the potential and caveats of using automated rhythm analysis as an opportunistic screening tool for heart pumping weakness. This study addresses the need for updated literature on how machine learning can improve cardiac care. The authors seek to clarify the diagnostic accuracy of these models in real-world clinical environments. By examining existing research, the team hopes to identify the strengths and limitations of current screening practices. This work is motivated by the increasing availability of medical treatments for heart failure prevention. The researchers intend to synthesize evidence regarding the use of these tools across diverse patient populations. They also aim to explore how these models perform when integrated with other diagnostic tests. This review provides a foundation for understanding the current state of automated cardiac diagnostics.

The review approach involved searching PubMed and Cochrane databases for relevant literature published between January 2010 and April 2022. Investigators focused on specific terms related to heart rhythm, failure, and machine learning. The team selected fifteen studies that reported diagnostic accuracy and potential confounding variables. This selection process filtered forty initial articles to ensure high-quality data inclusion. Reviewers categorized the selected papers into retrospective cohorts, prospective cohorts, and one case series. The researchers assessed how these models performed across different patient demographics. This methodology prioritized studies that evaluated the detection of reduced pumping function. The final synthesis compared various thresholds used to define cardiac dysfunction across the identified literature.

Key findings from the literature indicate that these models detect heart pumping weakness with a median area under the curve of 0.90. The reported sensitivity reached 83.3%, while the specificity was 87% across the analyzed cohorts. These algorithms maintained performance despite differences in patient age, sex, and comorbid conditions. The analysis reveals that these tools are particularly effective in non-cardiology settings. Combining this technology with natriuretic peptide testing further enhances the screening process. A notable observation is that false positive results may indicate future development of heart failure. No studies provided evidence regarding the impact of these tools on patient treatment or outcomes. The data confirms that this technology serves as a new biomarker for identifying cardiac dysfunction.

The authors propose that automated rhythm analysis functions as a novel biomarker for identifying heart pumping weakness. This synthesis suggests that these tools complement traditional blood tests and imaging procedures. Researchers emphasize that current evidence supports the integration of these models into routine clinical workflows. The review highlights that false positive findings may actually predict future cardiac decline. Authors note that no existing data confirms whether these tools improve actual patient survival rates. The team suggests that future randomized trials must evaluate the cost-effectiveness of these implementations. Experts argue that clinical significance remains unproven without direct evidence from prospective interventional studies. This analysis confirms that while diagnostic accuracy is high, therapeutic impact requires further rigorous investigation.